The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Overview of Breast Cancer Therapy
Open accessAbstract
Synopsis Breast cancer treatment is multidisciplinary. The majority of women with early-stage breast cancer are candidates for breast-conserving surgery with radiotherapy or mastectomy. The risk of local recurrence and the chance of survival does not differ with these approaches. Sentinel node biopsy is used for axillary staging, and individualized approaches are minimizing the need for axillary dissection in sentinel node-positive women. Adjuvant systemic therapy is used in the majority of women based on proven survival benefit, and molecular profiling to individualize treatment based on risk is now a clinical reality for patients with hormone receptor-positive cancers. Follow-up surveillance consists of a history, physical examination, and annual mammography. Following adjuvant systemic treatment, there is currently no evidence that routine imaging improves outcomes in the absence of symptoms. Novel modalities for early tumor detection are welcomed, but will need to demonstrate clinical utility in prospective trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022152 · Cited by 6,249
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2011) · The Lancet · doi:10.1016/s0140-6736(11)60993-8 · Cited by 3,075
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K.-A., Mooij, T. M., Roos-Blom, M.-J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7112 · Cited by 2,954
Giuliano, A. E. (2011) · JAMA · doi:10.1001/jama.2011.90 · Cited by 2,942
The National Comprehensive Cancer Network (NCCN).
Wood, E. H. (2004) · Journal of the Medical Library Association JMLA · Cited by 2,845
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, A., Pawlicki, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910383 · Cited by 2,775
Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
Gianni, L., Pienkowski, T., Im, Y.-H., Roman, L., Tseng, L.-M., Liu, M.-C., Lluch, A., Staroslawska, E., de la Haba-Rodriguez, J., Im, S.-A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70336-9 · Cited by 2,374
EBCTCG (Early Breast Cancer Trialists' Collaborative Group) (2014) · The Lancet · doi:10.1016/s0140-6736(14)60488-8 · Cited by 2,254
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Fisher, B., Bryant, J., Wolmark, N., Mamounas, E., Brown, A., Fisher, E. R., Wickerham, D. L., Begovic, M., DeCillis, A., Robidoux, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2672 · Cited by 2,165
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, M., Alencar, V. H. M., Badran, A., Bonfill, X., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61963-1 · Cited by 2,044
The Sentinel Node in Breast Cancer — A Multicenter Validation Study
Krag, D., Weaver, D., Ashikaga, T., Moffat, F., Klimberg, V. S., Shriver, C., Feldman, S., Kusminsky, R., Gadd, M., Kuhn, J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391401 · Cited by 2,018
Giuliano, A. E., Ballman, K. V., McCall, L., Beitsch, P. D., Brennan, M. B., Kelemen, P. R., Ollila, D. W., Hansen, N. M., Whitworth, P. W., Blumencranz, P. W., et al. (2017) · JAMA · doi:10.1001/jama.2017.11470 · Cited by 1,912
Self-citationLong-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Whelan, T. J., Pignol, J.-P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906260 · Cited by 1,878
Overgaard, M., Jensen, M.-B., Overgaard, J., Hansen, P. S., Rose, C., Andersson, M., Kamby, C., Kjaer, M., Gadeberg, C. C., Rasmussen, B. B., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09201-0 · Cited by 1,602
Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C., Winer, E. P., Gradishar, W. J., Davidson, N. E., Martino, S., Livingston, R., Ingle, J. N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.081 · Cited by 1,564
Haviland, J. S., Owen, J. R., Dewar, J. A., Agrawal, R. K., Barrett, J., Barrett-Lee, P. J., Dobbs, H. J., Hopwood, P., Lawton, P. A., Magee, B. J., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70386-3 · Cited by 1,470
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
von Minckwitz, G., Procter, M., de Azambuja, E., Zardavas, D., Benyunes, M., Viale, G., Suter, T., Arahmani, A., Rouchet, N., Clark, E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703643 · Cited by 1,411
Albain, K. S., Barlow, W. E., Shak, S., Hortobagyi, G. N., Livingston, R. B., Yeh, I.-T., Ravdin, P., Bugarini, R., Baehner, F. L., Davidson, N. E., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70314-6 · Cited by 1,407
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Perez, E. A., Olson, J. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510764 · Cited by 1,388
Hughes, K. S., Schnaper, L. A., Bellon, J. R., Cirrincione, C. T., Berry, D. A., McCormick, B., Muss, H. B., Smith, B. L., Hudis, C. A., Winer, E. P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2615 · Cited by 1,310
van Dongen, J. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1143 · Cited by 1,271
Schneeweiss, A., Chia, S., Hickish, T., Harvey, V., Eniu, A., Hegg, R., Tausch, C., Seo, J. H., Tsai, Y.-F., Ratnayake, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt182 · Cited by 1,264
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
Voduc, K. D., Cheang, M. C. U., Tyldesley, S., Gelmon, K., Nielsen, T. O., & Kennecke, H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9284 · Cited by 1,243
Holland, R., Veling, S. H. J., Mravunac, M., & Hendriks, J. H. C. L. (1985) · Cancer · doi:10.1002/1097-0142(19850901)56:5<979::aid-cncr2820560502>3.0.co;2-n · Cited by 1,133
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji250 · Cited by 1,118
van der Hage, J. A., van de Velde, C. J. H., Julien, J.-P., Tubiana-Hulin, M., Vandervelden, C., Duchateau, L., & Cooperating Investigators (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.22.4224 · Cited by 1,107
Cameron, D., Piccart-Gebhart, M. J., Gelber, R. D., Procter, M., Goldhirsch, A., de Azambuja, E., Castro, G., Untch, M., Smith, I., Gianni, L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32616-2 · Cited by 1,035
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Sparano, J. A., Wang, M., Martino, S., Jones, V., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Wood, W. C., & Davidson, N. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707056 · Cited by 997
Perez, E. A., Romond, E. H., Suman, V. J., Jeong, J.-H., Sledge, G., Geyer, C. E., Martino, S., Rastogi, P., Gralow, J., Swain, S. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5730 · Cited by 978
Kunkler, I. H., Williams, L. J., Jack, W. J. L., Cameron, D. A., & Dixon, J. M. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71221-5 · Cited by 904
Physical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review
Ballard-Barbash, R., Friedenreich, C. M., Courneya, K. S., Siddiqi, S. M., McTiernan, A., & Alfano, C. M. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs207 · Cited by 831
Houssami, N., Ciatto, S., Macaskill, P., Lord, S. J., Warren, R. M., Dixon, J. M., & Irwig, L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2108 · Cited by 831
Van Zee, K. J., Manasseh, D.-M. E., Bevilacqua, J. L. B., Boolbol, S. K., Fey, J. V., Tan, L. K., Borgen, P. I., Cody, H. S., & Kattan, M. W. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.015 · Cited by 818
Recht, A., Edge, S. B., Solin, L. J., Robinson, D. S., Estabrook, A., Fine, R. E., Fleming, G. F., Formenti, S., Hudis, C., Kirshner, J. J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1539 · Cited by 816
Burstein, H. J., Temin, S., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Rowden, D., Solky, A. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.2258 · Cited by 786
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Tolaney, S. M., Barry, W. T., Dang, C. T., Yardley, D. A., Moy, B., Marcom, P. K., Albain, K. S., Rugo, H. S., Ellis, M., Shapira, I., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406281 · Cited by 753
Self-citationAdjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
Pagani, O., Regan, M. M., Walley, B. A., Fleming, G. F., Colleoni, M., Láng, I., Gomez, H. L., Tondini, C., Burstein, H. J., Perez, E. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404037 · Cited by 749
Berry, D. A., Cirrincione, C., Henderson, I. C., Citron, M. L., Budman, D. R., Goldstein, L. J., Martino, S., Perez, E. A., Muss, H. B., Norton, L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1658 · Cited by 731
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
Goss, P. E., Ingle, J. N., Pritchard, K. I., Robert, N. J., Muss, H., Gralow, J., Gelmon, K., Whelan, T., Strasser-Weippl, K., Rubin, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604700 · Cited by 644
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
Turnbull, L., Brown, S., Harvey, I., Olivier, C., Drew, P., Napp, V., Hanby, A., & Brown, J. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62070-5 · Cited by 642
Moran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3481-4 · Cited by 612
Self-citationPoggi, M. M., Danforth, D. N., Sciuto, L. C., Smith, S. L., Steinberg, S. M., Liewehr, D. J., Menard, C., Lippman, M. E., Lichter, A. S., & Altemus, R. M. (2003) · Cancer · doi:10.1002/cncr.11580 · Cited by 569
Voogd, A. C., Nielsen, M., Peterse, J. L., Blichert-Toft, M., Bartelink, H., Overgaard, M., van Tienhoven, G., Andersen, K. W., Sylvester, R. J., van Dongen, J. A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1688 · Cited by 562
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Muss, H. B., Berry, D. A., Cirrincione, C. T., Theodoulou, M., Mauer, A. M., Kornblith, A. B., Partridge, A. H., Dressler, L. G., Cohen, H. J., Becker, H. P., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810266 · Cited by 554
Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy
Moore, H. C. F., Unger, J. M., Phillips, K.-A., Boyle, F., Hitre, E., Porter, D., Francis, P. A., Goldstein, L. J., Gomez, H. L., Vallejos, C. S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413204 · Cited by 553
Sentinel Lymph Node Biopsy in Breast Cancer: Ten-Year Results of a Randomized Controlled Study
Veronesi, U., Viale, G., Paganelli, G., Zurrida, S., Luini, A., Galimberti, V., Veronesi, P., Intra, M., Maisonneuve, P., Zucca, F., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181c0e92a · Cited by 551
Houssami, N., Macaskill, P., Luke Marinovich, M., & Morrow, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3480-5 · Cited by 532
Self-citationGiuliano, A. E., Ballman, K., McCall, L., Beitsch, P., Whitworth, P. W., Blumencranz, P., Leitch, A. M., Saha, S., Morrow, M., & Hunt, K. K. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001863 · Cited by 497
Self-citationWapnir, I. L., Anderson, S. J., Mamounas, E. P., Geyer, C. E., Jeong, J.-H., Tan-Chiu, E., Fisher, B., & Wolmark, N. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3273 · Cited by 466
Anderson, S. J., Wapnir, I., Dignam, J. J., Fisher, B., Mamounas, E. P., Jeong, J.-H., Geyer, C. E., Wickerham, D. L., Costantino, J. P., & Wolmark, N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8424 · Cited by 458
Moran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.3935 · Cited by 451
Self-citationRecht, A., Gray, R., Davidson, N. E., Fowble, B. L., Solin, L. J., Cummings, F. J., Falkson, G., Falkson, H. C., Taylor, S. G., & Tormey, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1689 · Cited by 440
Neoadjuvant chemotherapy for operable breast cancer
Mieog, J. S. D., van der Hage, J. A., & van de Velde, C. J. H. (2007) · British Journal of Surgery · doi:10.1002/bjs.5894 · Cited by 433
Xing, Y., Foy, M., Cox, D. D., Kuerer, H. M., Hunt, K. K., & Cormier, J. N. (2006) · Journal of British Surgery · doi:10.1002/bjs.5209 · Cited by 402
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
Lowery, A. J., Kell, M. R., Glynn, R. W., Kerin, M. J., & Sweeney, K. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1891-6 · Cited by 389
Engel, J., Kerr, J., Schlesinger-Raab, A., Sauer, H., & Holzel, D. (2004) · The Breast Journal · doi:10.1111/j.1075-122x.2004.21323.x · Cited by 381
Katipamula, R., Degnim, A. C., Hoskin, T., Boughey, J. C., Loprinzi, C., Grant, C. S., Brandt, K. R., Pruthi, S., Chute, C. G., Olson, J. E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4225 · Cited by 373
Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients
Möbus, V. (2016) · Breast Care · doi:10.1159/000444004 · Cited by 354
Recht, A., Comen, E. A., Fine, R. E., Fleming, G. F., Hardenbergh, P. H., Ho, A. Y., Hudis, C. A., Hwang, E. S., Kirshner, J. J., Morrow, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.1188 · Cited by 340
Self-citationSurgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer
Morrow, M. (2009) · JAMA · doi:10.1001/jama.2009.1450 · Cited by 333
Self-citationClinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy
King, T. A., Sakr, R., Patil, S., Gurevich, I., Stempel, M., Sampson, M., & Morrow, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.4041 · Cited by 330
Self-citationPeters, N. H. G. M., van Esser, S., van den Bosch, M. A. A. J., Storm, R. K., Plaisier, P. W., van Dalen, T., Diepstraten, S. C. E., Weits, T., Westenend, P. J., Stapper, G., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.035 · Cited by 326
Visvanathan, K., Hurley, P., Bantug, E., Brown, P., Col, N. F., Cuzick, J., Davidson, N. E., DeCensi, A., Fabian, C., Ford, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.3122 · Cited by 307
Self-citationSafety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies
Azim, H. A., Santoro, L., Pavlidis, N., Gelber, S., Kroman, N., Azim, H., & Peccatori, F. A. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.007 · Cited by 269
Long-term oncological results of breast conservative treatment with oncoplastic surgery
Rietjens, M., Urban, C. A., Rey, P. C., Mazzarol, G., Maisonneuve, P., Garusi, C., Intra, M., Yamaguchi, S., Kaur, N., De Lorenzi, F., et al. (2007) · The Breast · doi:10.1016/j.breast.2007.01.008 · Cited by 268
Houssami, N., Turner, R. M., & Morrow, M. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4324-3 · Cited by 243
Self-citationEffect of obesity and other lifestyle factors on mortality in women with breast cancer
Dal Maso, L., Zucchetto, A., Talamini, R., Serraino, D., Stocco, C. F., Vercelli, M., Falcini, F., Franceschi, S., & for Prospective Analysis of Case‐control studies on Environmental factors and health (PACE) study group (2008) · International Journal of Cancer · doi:10.1002/ijc.23747 · Cited by 238
Hopwood, P., Haviland, J. S., Sumo, G., Mills, J., Bliss, J. M., & Yarnold, J. R. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70382-1 · Cited by 234
Härtl, K., Janni, W., Kästner, R., Sommer, H., Strobl, B., Rack, B., & Stauber, M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg289 · Cited by 229
Sparano, J. A., Zhao, F., Martino, S., Ligibel, J. A., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Wood, W. C., & Davidson, N. E. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.9271 · Cited by 222
Jagsi, R., Li, Y., Morrow, M., Janz, N., Alderman, A., Graff, J., Hamilton, A., Katz, S., & Hawley, S. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000908 · Cited by 220
Self-citationArndt, V., Stegmaier, C., Ziegler, H., & Brenner, H. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0418-y · Cited by 210
Comparison of Skin-Sparing Mastectomy Versus Non–Skin-Sparing Mastectomy for Breast Cancer
Lanitis, S., Tekkis, P. P., Sgourakis, G. G., Dimopoulos, N., Mufti, R. A., & Hadjiminas, D. J. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181d35bf8 · Cited by 203
Margolese, R. G., Cecchini, R. S., Julian, T. B., Ganz, P. A., Costantino, J. P., Vallow, L. A., Albain, K. S., Whitworth, P. W., Cianfrocca, M. E., Brufsky, A. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01168-x · Cited by 198
Betof, A. S., Dewhirst, M. W., & Jones, L. W. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.05.001 · Cited by 197
Houssami, N., Turner, R., Macaskill, P., Turnbull, L. W., McCready, D. R., Tuttle, T. M., Vapiwala, N., & Solin, L. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.7515 · Cited by 192
Kelly, A. M., Dwamena, B., Cronin, P., & Carlos, R. C. (2009) · Academic Radiology · doi:10.1016/j.acra.2009.01.026 · Cited by 171
Slamon, D., EIERMANN, W., Robert, N., Giermek, J., Martín, M., Jasiówka, M., Mackey, J., Chan, A., Liu, M.-C., Pintér, T., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.sabcs15-s5-04 · Cited by 154
Swain, S. M., Tang, G., Geyer, C. E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.1275 · Cited by 145
Broët, P., Scholl, S. M., de la Rochefordière, A., Fourquet, A., Moreau, T., Rycke, Y. D., Asselain, B. J. R., & Pouillart, P. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006339918798 · Cited by 119
Toxicity of radiotherapy in patients with collagen vascular disease
Lin, A., Abu-Isa, E. I., Griffith, K. A., & Ben‐Josef, E. (2008) · Cancer · doi:10.1002/cncr.23591 · Cited by 115
Breast-conserving therapy in the setting of collagen vascular disease.
Chen, A. M., Obedian, E., & Haffty, B. G. (2002) · PubMed · Cited by 113
Phan, C., Mindrum, M. R., Silverman, C. I., Paris, K. J., & Spanos, W. J. (2003) · The Cancer Journal · doi:10.1097/00130404-200311000-00005 · Cited by 84
Sharma, R., Bedrosian, I., Lucci, A., Hwang, R. F., Rourke, L. L., Qiao, W., Buchholz, T. A., Kronowitz, S. J., Krishnamurthy, S., Babiera, G. V., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1089-x · Cited by 83
Pilewskie, M. L., & King, T. A. (2014) · Cancer · doi:10.1002/cncr.28700 · Cited by 41
Oncologic Outcomes After Nipple-Sparing Mastectomy
Moo, T. A., Pinchinat, T., Mays, S., Landers, A., Christos, P. J., Alabdulkareem, H., Tousimis, E. A., Swistel, A. J., & Simmons, R. M. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5366-1 · Cited by 41
Self-citationFancellu, A., Soro, D., Castiglia, P., Marras, V., Melis, M., Cottu, P., Cherchi, A., Spanu, A., Mulas, S., Pusceddu, C., et al. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.10.002 · Cited by 36
Hoffman, K. E., Mittendorf, E. A., & Buchholz, T. A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70038-4 · Cited by 32
Cited by
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z.-S., Kumar, A., Vishakha, Behl, T., Jha, S. K., & Tang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01805-y · Cited by 554
Ogier du Terrail, J., Leopold, A., Joly, C., Béguier, C., Andreux, M., Maussion, C., Schmauch, B., Tramel, E. W., Bendjebbar, E., Zaslavskiy, M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02155-w · Cited by 217
Targeting Breast Cancer: An Overlook on Current Strategies
Iacopetta, D., Ceramella, J., Baldino, N., Sinicropi, M., & Catalano, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043643 · Cited by 88
Metadata
- Authors
- Moo, T.-A., Sanford, R., Dang, C., & Morrow, M.
- Venue
- PET Clinics
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 13
- Issue
- 3
- Pages
- 339-354
- ISSN
- 1556-8598 (ISSN-L)
- OpenAlex
- W2811485525
- Cited by
- 551
- References
- 98
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.